West Pharmaceutical Dividends
| WST Stock | USD 237.03 -3.30 -1.37% |
West |
The dividend dataset for West Pharmaceutical contains 10 records. All figures are drawn from reported dividend activity.
Recent Dividend Payments (per share)
Dividends Paid |
| Timeline |
Forward Dividend Income Per Share
Dividend payments represent a portion of West Pharmaceutical's earnings that management elects to return to shareholders, which is why expected dividend income matters for investors building an income-oriented thesis around West Pharmaceutical Services. Used correctly, this figure becomes more informative when it is evaluated beside dividend history, earnings quality, and the likelihood of payout continuity.
$0.69 |
Next 12 Months
West Pharmaceutical Services expected dividend income per share adjusted for ongoing price standard deviation
Past Distributions to Stockholders
The distribution history of West Pharmaceutical Services may also provide insight into how the Stock has approached shareholder returns over time. This view is most useful when investors want to judge whether the dividend timeline reflects an intentional policy or a less predictable distribution record.
| 4th of February 2026 | ||
| 19th of November 2025 | ||
| 6th of August 2025 | ||
| 7th of May 2025 | ||
| 11th of February 2025 | ||
| 7th of February 2025 | ||
| 20th of November 2024 | ||
| 7th of August 2024 | ||
| 15th of May 2024 | ||
| 1st of May 2024 |
Dividends Overview and Assumptions
This block organizes West Pharmaceutical dividend cadence and payout stability for income-focused review. The most recent distribution was $0.22 on February 4, 2026.
The analytics block for West Pharmaceutical Services relies on periodic company reporting and market reference feeds, with quality checks and normalization applied before rendering. Timing can vary by data vendor.
This content is curated and reviewed by:
Vlad Skutelnik - Macroaxis ContributorBook value captures West accounting equity, while market value captures the collective view of participants. West Pharmaceutical's market capitalization is 17.09 B. The 5.38 P/B ratio shows West Pharmaceutical carries a substantial premium over its balance-sheet equity. Enterprise value stands at 16.62 B. For West Pharmaceutical, intrinsic value estimation helps reconcile what the market pays with what the books show.
Value and price for West Pharmaceutical may converge over time but can differ substantially in any given period. Exchange pricing for West Pharmaceutical reflects real-time supply and demand across active participants.